Healthcare provider profile · identity verified

Kenneth David Hershman, M.D.

Internal Medicine · MIAMI, FL · NPI 1144219270

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	464	151
Alprazolam	Alprazolam	305	52
Losartan Potassium	Losartan Potassium	282	90
Omeprazole	Omeprazole	225	78
Amlodipine Besylate	Amlodipine Besylate	224	73
Metformin Hcl	Metformin Hcl	205	66
Lisinopril	Lisinopril	191	64
Levothyroxine Sodium	Levothyroxine Sodium	187	61
Gabapentin	Gabapentin	158	49
Metoprolol Succinate	Metoprolol Succinate	149	52
Tamsulosin Hcl	Tamsulosin Hcl	135	47
Temazepam	Temazepam	124	18
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	118	49
Hydrochlorothiazide	Hydrochlorothiazide	116	32
Trazodone Hcl	Trazodone Hcl	115	40
Albuterol Sulfate Hfa	Albuterol Sulfate	110	27
Metoprolol Tartrate	Metoprolol Tartrate	108	31
Azithromycin	Azithromycin	104	82
Ibuprofen	Ibuprofen	101	40
Methylprednisolone	Methylprednisolone	101	79
Tramadol Hcl	Tramadol Hcl	101	30
Rosuvastatin Calcium	Rosuvastatin Calcium	98	33
Simvastatin	Simvastatin	98	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	96	31
Ozempic	Semaglutide	93	17
Zolpidem Tartrate	Zolpidem Tartrate	91	20
Clopidogrel	Clopidogrel Bisulfate	81	26
Clonazepam	Clonazepam	79	19
Fluticasone Propionate	Fluticasone Propionate	78	26
Pantoprazole Sodium	Pantoprazole Sodium	78	28
Potassium Chloride	Potassium Chloride	62	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	20
Atenolol	Atenolol	60	18
Famotidine	Famotidine	59	19
Eliquis	Apixaban	57	18
Naproxen	Naproxen	57	25
Dicyclomine Hcl	Dicyclomine Hcl	56	29
Furosemide	Furosemide	56	22
Carvedilol	Carvedilol	55	20
Donepezil Hcl	Donepezil Hcl	53	18
Doxazosin Mesylate	Doxazosin Mesylate	53	14
Finasteride	Finasteride	53	23
Diclofenac Sodium	Diclofenac Sodium	52	16
Sertraline Hcl	Sertraline Hcl	49	18
Meloxicam	Meloxicam	48	21
Lorazepam	Lorazepam	47	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	11
Escitalopram Oxalate	Escitalopram Oxalate	44	15
Alendronate Sodium	Alendronate Sodium	43	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	24
Celecoxib	Celecoxib	42	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	41	35
Sildenafil Citrate	Sildenafil Citrate	40	13
Ibandronate Sodium	Ibandronate Sodium	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Glipizide	Glipizide	37	suppressed
Meclizine Hcl	Meclizine Hcl	36	15
Montelukast Sodium	Montelukast Sodium	36	11
Lantus	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Xarelto	Rivaroxaban	35	12
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	11
Memantine Hcl	Memantine Hcl	31	12
Prednisone	Prednisone	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Nebivolol Hcl	Nebivolol Hcl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Allopurinol	Allopurinol	25	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Cephalexin	Cephalexin	25	21
Ketoconazole	Ketoconazole	25	suppressed
Spironolactone	Spironolactone	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Indomethacin	Indomethacin	21	11
Novolog	Insulin Aspart	21	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	20	suppressed
Ammonium Lactate	Ammonium Lactate	20	11
Latanoprost	Latanoprost	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	15
Ezetimibe	Ezetimibe	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	11
Valsartan	Valsartan	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	18	13
Ciclopirox	Ciclopirox	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Lovastatin	Lovastatin	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Metronidazole	Metronidazole	15	12
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	14	12
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Estradiol	Estradiol	12	suppressed
Ibu	Ibuprofen	12	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error